Reshape Lifesciences Stock Price History
| RSLS Stock | USD 1.15 0.21 15.44% |
Below is the normalized historical share price chart for ReShape Lifesciences extending back to October 06, 2016. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of ReShape Lifesciences stands at 1.15, as last reported on the 26th of February, with the highest price reaching 1.32 and the lowest price hitting 1.11 during the day.
If you're considering investing in ReShape Stock, it is important to understand the factors that can impact its price. ReShape Lifesciences maintains Sharpe Ratio (i.e., Efficiency) of -0.21, which implies the firm had a -0.21 % return per unit of standard deviation over the last 3 months. ReShape Lifesciences exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check ReShape Lifesciences' Market Risk Adjusted Performance of (0.82), risk adjusted performance of (0.12), and Coefficient Of Variation of (571.58) to confirm the risk estimate we provide.
At this time, ReShape Lifesciences' Common Stock Shares Outstanding is comparatively stable compared to the past year. Other Stockholder Equity is likely to gain to about 775.6 M in 2025, whereas Total Stockholder Equity is likely to drop slightly above 7.3 M in 2025. . Price To Sales Ratio is likely to drop to 0.19 in 2025. Price Earnings Ratio is likely to gain to -0.12 in 2025. ReShape Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 15th of November 2007 | 200 Day MA 9.5288 | 50 Day MA 6.1109 | Beta 1.346 |
ReShape |
Sharpe Ratio = -0.2066
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | RSLS |
Estimated Market Risk
| 9.76 actual daily | 87 87% of assets are less volatile |
Expected Return
| -2.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.21 actual daily | 0 Most of other assets perform better |
Based on monthly moving average ReShape Lifesciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ReShape Lifesciences by adding ReShape Lifesciences to a well-diversified portfolio.
Price Book 3.0228 | Enterprise Value Ebitda (0.02) | Price Sales 0.4645 | Shares Float 466.6 K | Wall Street Target Price 1 |
ReShape Lifesciences Stock Price History Chart
There are several ways to analyze ReShape Stock price data. The simplest method is using a basic ReShape candlestick price chart, which shows ReShape Lifesciences price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | November 29, 2024 | 5.94 |
| Lowest Price | February 18, 2025 | 1.08 |
ReShape Lifesciences February 26, 2025 Stock Price Synopsis
Various analyses of ReShape Lifesciences' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell ReShape Stock. It can be used to describe the percentage change in the price of ReShape Lifesciences from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of ReShape Stock.| ReShape Lifesciences Price Daily Balance Of Power | (1.00) | |
| ReShape Lifesciences Price Action Indicator | (0.17) | |
| ReShape Lifesciences Accumulation Distribution | 347,523 | |
| ReShape Lifesciences Price Rate Of Daily Change | 0.85 |
ReShape Lifesciences February 26, 2025 Stock Price Analysis
ReShape Stock Price History Data
The price series of ReShape Lifesciences for the period between Thu, Nov 28, 2024 and Wed, Feb 26, 2025 has a statistical range of 4.86 with a coefficient of variation of 29.91. The price distribution for the period has arithmetic mean of 4.18. The median price for the last 90 days is 4.52. The company completed stock split (1:58) on 23rd of September 2024. ReShape Lifesciences had dividends distributed to its stock-holders on 2019-07-25.| Open | High | Low | Close | Volume | ||
| 02/25/2025 | 1.32 | 1.32 | 1.11 | 1.15 | 2,184,429 | |
| 02/24/2025 | 1.16 | 1.41 | 1.05 | 1.36 | 4,214,359 | |
| 02/21/2025 | 1.20 | 1.24 | 1.02 | 1.12 | 2,006,979 | |
| 02/20/2025 | 1.33 | 1.36 | 1.18 | 1.23 | 3,430,500 | |
| 02/19/2025 | 1.33 | 1.85 | 1.25 | 1.36 | 37,382,566 | |
| 02/18/2025 | 1.18 | 1.20 | 1.01 | 1.08 | 7,328,900 | |
| 02/14/2025 | 2.57 | 2.59 | 2.32 | 2.33 | 118,352 | |
| 02/13/2025 | 2.79 | 2.89 | 2.42 | 2.54 | 77,586 | |
| 02/12/2025 | 2.70 | 2.91 | 2.62 | 2.79 | 71,463 | |
| 02/11/2025 | 2.76 | 2.76 | 2.68 | 2.71 | 11,433 | |
| 02/10/2025 | 2.83 | 2.83 | 2.63 | 2.81 | 23,514 | |
| 02/07/2025 | 3.07 | 3.07 | 2.59 | 2.83 | 38,073 | |
| 02/06/2025 | 3.32 | 3.36 | 2.90 | 3.08 | 76,395 | |
| 02/05/2025 | 3.57 | 3.57 | 3.05 | 3.32 | 53,028 | |
| 02/04/2025 | 3.55 | 3.75 | 3.45 | 3.57 | 28,600 | |
| 02/03/2025 | 3.66 | 3.77 | 3.23 | 3.55 | 382,900 | |
| 01/31/2025 | 3.77 | 3.92 | 3.77 | 3.77 | 9,100 | |
| 01/30/2025 | 3.84 | 3.92 | 3.71 | 3.77 | 8,200 | |
| 01/29/2025 | 3.80 | 3.94 | 3.50 | 3.85 | 51,000 | |
| 01/28/2025 | 4.26 | 4.28 | 3.61 | 3.65 | 37,300 | |
| 01/27/2025 | 4.36 | 4.48 | 4.35 | 4.48 | 14,300 | |
| 01/24/2025 | 4.46 | 4.47 | 4.34 | 4.44 | 12,000 | |
| 01/23/2025 | 4.33 | 4.47 | 4.20 | 4.46 | 36,400 | |
| 01/22/2025 | 4.53 | 4.53 | 4.17 | 4.31 | 25,200 | |
| 01/21/2025 | 4.69 | 4.72 | 4.42 | 4.53 | 12,600 | |
| 01/17/2025 | 4.80 | 4.86 | 4.52 | 4.52 | 21,800 | |
| 01/16/2025 | 4.88 | 4.91 | 4.52 | 4.67 | 14,000 | |
| 01/15/2025 | 4.80 | 5.00 | 4.68 | 4.93 | 16,700 | |
| 01/14/2025 | 4.94 | 5.15 | 4.62 | 4.66 | 42,300 | |
| 01/13/2025 | 4.80 | 5.19 | 4.35 | 5.00 | 99,000 | |
| 01/10/2025 | 4.52 | 4.59 | 4.43 | 4.50 | 7,700 | |
| 01/09/2025 | 4.76 | 4.79 | 4.76 | 4.79 | 6.00 | |
| 01/08/2025 | 4.72 | 4.77 | 4.59 | 4.72 | 14,100 | |
| 01/07/2025 | 4.86 | 5.12 | 4.70 | 4.70 | 27,400 | |
| 01/06/2025 | 4.75 | 5.10 | 4.71 | 4.86 | 26,700 | |
| 01/03/2025 | 4.60 | 4.82 | 4.60 | 4.70 | 16,600 | |
| 01/02/2025 | 4.49 | 4.70 | 4.34 | 4.56 | 20,000 | |
| 12/31/2024 | 4.63 | 4.63 | 4.39 | 4.46 | 7,200 | |
| 12/30/2024 | 4.51 | 4.55 | 4.47 | 4.52 | 11,100 | |
| 12/27/2024 | 4.75 | 4.75 | 4.55 | 4.55 | 7,500 | |
| 12/26/2024 | 4.40 | 4.75 | 4.40 | 4.75 | 11,400 | |
| 12/24/2024 | 4.37 | 4.46 | 4.37 | 4.46 | 3,500 | |
| 12/23/2024 | 4.38 | 4.49 | 4.26 | 4.26 | 8,500 | |
| 12/20/2024 | 4.38 | 4.69 | 4.28 | 4.38 | 41,500 | |
| 12/19/2024 | 4.50 | 4.73 | 4.35 | 4.47 | 20,700 | |
| 12/18/2024 | 4.59 | 4.80 | 4.50 | 4.50 | 20,700 | |
| 12/17/2024 | 4.48 | 4.70 | 4.09 | 4.59 | 48,100 | |
| 12/16/2024 | 4.89 | 4.89 | 4.36 | 4.48 | 39,000 | |
| 12/13/2024 | 4.84 | 4.84 | 4.62 | 4.72 | 9,400 | |
| 12/12/2024 | 4.81 | 4.85 | 4.59 | 4.68 | 14,200 | |
| 12/11/2024 | 5.00 | 5.04 | 4.48 | 4.83 | 44,500 | |
| 12/10/2024 | 5.03 | 5.09 | 4.87 | 5.04 | 17,000 | |
| 12/09/2024 | 5.19 | 5.19 | 4.75 | 4.99 | 36,100 | |
| 12/06/2024 | 4.99 | 5.20 | 4.81 | 4.97 | 43,100 | |
| 12/05/2024 | 5.49 | 5.51 | 4.90 | 4.94 | 64,600 | |
| 12/04/2024 | 5.58 | 5.68 | 5.43 | 5.49 | 19,400 | |
| 12/03/2024 | 5.63 | 5.63 | 5.26 | 5.58 | 19,000 | |
| 12/02/2024 | 5.83 | 5.83 | 5.51 | 5.56 | 52,900 | |
| 11/29/2024 | 5.74 | 5.94 | 5.62 | 5.94 | 24,600 | |
| 11/28/2024 | 5.63 | 5.63 | 5.63 | 5.63 | 36.00 | |
| 11/27/2024 | 5.73 | 5.76 | 5.49 | 5.75 | 30,500 |
About ReShape Lifesciences Stock history
ReShape Lifesciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ReShape is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in ReShape Lifesciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ReShape Lifesciences stock prices may prove useful in developing a viable investing in ReShape Lifesciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 92.4 K | 128.9 K | |
| Net Loss | -41.6 M | -43.7 M |
ReShape Lifesciences Stock Technical Analysis
ReShape Lifesciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Funds Screener Now
Funds ScreenerFind actively-traded funds from around the world traded on over 30 global exchanges |
| All Next | Launch Module |
ReShape Lifesciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for ReShape Lifesciences' price direction in advance. Along with the technical and fundamental analysis of ReShape Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of ReShape to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.12) | |||
| Jensen Alpha | (1.67) | |||
| Total Risk Alpha | (1.73) | |||
| Treynor Ratio | (0.83) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for ReShape Stock Analysis
When running ReShape Lifesciences' price analysis, check to measure ReShape Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ReShape Lifesciences is operating at the current time. Most of ReShape Lifesciences' value examination focuses on studying past and present price action to predict the probability of ReShape Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ReShape Lifesciences' price. Additionally, you may evaluate how the addition of ReShape Lifesciences to your portfolios can decrease your overall portfolio volatility.